Page 30 - பல்கலைக்கழகம் ஆஃப் ரோசெஸ்டர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study shows COVID-19 organ-specific outcomes depend on anti-spike glycoprotein antibodies A recent study from the University of Rochester reveals how the biodistribution kinetics and the affinity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for many different organs in the human body can be affected by antibodies targeting viral spike glycoprotein. The paper is currently available on the bioRxiv preprint server while it undergoes peer review. The ongoing coronavirus disease 2019 (COVID-19) is caused by the SARS-CoV-2, a virus that can enter host cells by using its spike glycoprotein to bind with the angiotensin-converting enzyme 2 (ACE2) receptor widely distributed in tissues and organs.

University of rochesterNew yorkUnited statesMolly bradyDepartment of neuroscienceபல்கலைக்கழகம் ஆஃப் ரோசெஸ்டர்புதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்மாலீ பிராடிதுறை ஆஃப் நரம்பியல்